Table 3: Importance scores for the impact of comorbid depression-diabetes on the proteomic profile of MCI cases.
| Without introducing diabetes and depression | Diabetes only | Depression only | Comorbid (Diabetes and depression) | Neither (No diabetes or depression) |
| IL10 23.3 | FABP 16.2 | TNFalpha 19.9 | Eotaxin3 8.0 | TNFalpha 9.1 |
| TARC 20.0 | IL10 11.8 | IL10 11.9 | TARC 7.9 | B2M 9.0 |
| TNFalpha 19.3 | TNFalpha 8.6 | IL7 8.2 | sVCAM1 7.0 | TPO 8.7 |
| FABP 17.4 | IL6 6.3 | FVII 8.2 | TPO 5.6 | IL5 7.5 |
| IL5 15.0 | TARC 6.1 | TNC 7.8 | CRP 5.2 | IL18 6.8 |
| SAA 14.1 | sICAM1 5.8 | FABP 7.4 | TNFalpha 4.8 | sVCAM1 6.2 |
| PPY 12.6 | PPY 4.9 | TARC 7.2 | PPY 4.5 | sICAM1 6.2 |
| IL6 12.6 | TPO 4.6 | IL6 6.7 | sICAM1 4.0 | FABP 6.1 |
| IL1beta 12.3 | Eotaxin3 4.6 | SAA 6.0 | IL1beta 3.5 | IL6 6.0 |
| TPO 12.3 | IL1beta 3.9 | B2M 5.4 | IL5 3.5 | PPY 6.0 |
| CRP 10.5 | SAA 3.7 | TPO 4.3 | SAA 3.3 | CRP 5.4 |
| TNC 9.8 | B2M 3.5 | I309 3.7 | IL18 2.8 | TARC 5.3 |
| B2M 7.5 | FVII 3.1 | Eotaxin3 3.6 | TNC 2.5 | Eotaxin3 4.4 |
| Eotaxin3 7.4 | IL18 2.7 | sVCAM1 2.5 | IL6 2.4 | IL1beta 3.6 |
| sVCAM1 6.3 | I309 2.6 | IL1beta 2.4 | IL7 2.4 | IL10 3.3 |
| IL7 6.0 | CRP 2.5 | IL18 2.2 | B2M 1.7 | IL7 2.6 |
| sICAM1 5.9 | IL5 1.9 | IL5 2.0 | FVII 1.7 | SAA 2.4 |
| FVII 5.5 | TNC 1.4 | sICAM1 0.9 | IL10 1.3 | TNC 2.3 |
| I309 4.8 | sVCAM1 1.1 | CRP 0.8 | I309 0.7 | A2M 1.9 |
| IL18 2.0 | IL7 0.6 | A2M 0.5 | FABP 0.1 | I309 1.8 |
| A2M 0.6 | A2M 0.1 | PPY 0.4 | A2M 0.1 | FVII 0.7 |